16,197 results match your criteria: " Australia; The George Institute for Global Health[Affiliation]"

Drug therapy versus placebo or usual care for comatose survivors of cardiac arrest; a systematic review with meta-analysis.

Resuscitation

December 2024

Regional Intensive Care Unit, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, UK; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, UK. Electronic address:

Background: In Europe, approximately 291,000 cardiac arrests occur annually. Despite critical care therapy, hospital mortality remains high. This systematic review assessed whether, in comatose survivors of cardiac arrest, any drug therapy, compared to placebo or usual care, improves outcomes.

View Article and Find Full Text PDF

Association of alcohol with lung cancer risk in men with different growth hormone receptor genotypes.

Lung Cancer

December 2024

Kuakini-Honolulu Heart Program, Center of Biomedical Research Excellence (COBRE) for Clinical and Translational Research on Aging, Department of Research, Kuakini Medical Center, Honolulu, HI, USA; Department of Geriatric Medicine, University of Hawaii, Honolulu, HI, USA. Electronic address:

Objective: To test whether genetic variants of the growth hormone receptor gene (GHR) modulate the effect of lifestyle variables on lung cancer (LC) risk.

Materials And Methods: This population-based cohort study involved 6,439 men from the Japan-Hawaii Cancer study drawn from the Kuakini Honolulu Heart Program who were cancer-free at baseline examination (1965-1968; age 45-68 years) and followed-up until December 1999. We determined the association of GHR SNP rs4130113 genotypes GHR-AA (common allele A homozygotes) and GHR-G (minor allele G carriage) with alcohol drinking, BMI, physical activity and cigarette smoking in relation to LC and non-small cell LC (NSCLC).

View Article and Find Full Text PDF
Article Synopsis
  • Two polyploid grass weeds in Australia, Hordeum glaucum and Bromus diandrus, have developed resistance to glyphosate through the amplification of the EPSPS gene, which is crucial for their survival.
  • Research involved analyzing the EPSPS gene's genomic structure using molecular cytogenetic methods, showing that resistant plants have significantly more copies of the gene compared to susceptible ones.
  • The findings suggest that unequal crossover during meiosis may be responsible for the gene duplication, contributing to the evolution of glyphosate resistance in these weed species.
View Article and Find Full Text PDF

The accelerated approval (AA) pathway was established by the United States Food and Drug Administration (FDA) to provide earlier access to therapies for patients with serious medical conditions and unmet medical needs. Since its inception, the AA pathway has been used for novel treatments across different therapeutic areas, but most prominently in oncology, including the immune checkpoint inhibitor class. This review article describes the history of regulatory approvals for pembrolizumab, an immunotherapy agent targeting programmed death receptor-1 (PD-1), and use of the AA pathway and the corresponding regulatory decisions made by the FDA.

View Article and Find Full Text PDF

Frontotemporal dementia (FTD) is one of the leading causes of young-onset dementia before age 65, typically manifesting as abnormal behavior (in behavioral variant FTD) or language impairment (in primary progressive aphasia). Although FTD affects all populations across the globe, knowledge regarding the pathophysiology and genetics derives primarily from studies conducted in North America and Western Europe. Globally, biomedical research for FTD is hindered by variable access to diagnosis, discussed in this group's earlier article, and by reduced access to expertise, funding, and infrastructure.

View Article and Find Full Text PDF
Article Synopsis
  • Pexidartinib is a drug used for treating tenosynovial giant cell tumor (TGCT) in patients where surgery isn't an option, and this study looked at the effects of stopping and then restarting the medication.
  • It was a phase 4 global study involving patients who had benefited from pexidartinib, allowing them to either continue treatment or stop with the option to restart later, monitoring their tumor progression and quality of life.
  • Results showed that while about 54.5% of patients who stopped the drug experienced disease progression, none of those who continued treatment saw their condition worsen over a 24-month period.
View Article and Find Full Text PDF

Intravenous pembrolizumab 400 mg every 6 weeks was approved across tumor types based on pharmacokinetic modeling, which showed exposures consistent with previous standard dosing of 200 mg or 2 mg/kg every 3 weeks, and early results of cohort B of the phase 1 KEYNOTE-555 study. Results after ≥1 year of potential follow-up for all patients in cohort B of KEYNOTE-555 are presented. Patients aged ≥18 years with previously untreated stage III/IV melanoma received pembrolizumab 400 mg every 6 weeks for ≤18 cycles.

View Article and Find Full Text PDF

Current and emerging therapies as potential treatment for people with von Willebrand disease.

Expert Rev Hematol

December 2024

School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Westmead, New South Wales, Australia.

Article Synopsis
  • Von Willebrand disease (VWD) is the most common inherited bleeding disorder caused by issues with von Willebrand factor (VWF), often leading to misdiagnosis and improper management.
  • Treatment mainly involves replacing the deficient or defective VWF, with additional therapies tailored to specific patient needs, including new treatment options like FVIII replacement and antibody-based strategies.
  • The future of VWD treatment is expected to evolve significantly with personalized approaches, offering tailored therapies based on individual patient circumstances and treatment goals.
View Article and Find Full Text PDF

Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study Cohort.

Radiology

November 2024

From the Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin & Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Lindenberger Weg 80, 13125 Berlin, Germany (C.C., H.Z., A.U.B., F.P.); NeuroCure Clinical Research Ctr (C.C., H.Z., A.U.B., J.W., F.P.), Dept of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany (C.C.); Medical Image Analysis Center, Basel, Switzerland (V.C.e.S., E.G., D.M.); Paulista School of Medicine, Dept of Neurology and Neurosurgery (D.B.B.), Dept of Diagnostic Imaging, Universidade Federal de São Paulo, São Paulo, Brazil (M.I.I.); Koc Univ, School of Medicine Neurology Dept and Istanbul Univ, Cerrahpasa School of Medicine, Neurology Dept, Istanbul, Turkey (A.A.); Dept of Neurology, Istanbul Univ, Cerrahpasa Faculty of Medicine, Istanbul, Turkey (U.T.); Div of Neurology, Dept of Medicine, Siriraj Hosp, Mahidol Univ, Bangkok, Thailand (S.S.); Bumrungrad International Hosp, Bangkok, Thailand (S.S.); Center for Advanced Neurologic Research, KS Hegde Medical Academy, Nitte Univ, Mangalore, India (L.P., A.D.); Dept of Neurology, Hosp de S. João, Al. Hernâni Monteiro, Porto, Portugal (M.J.S., R.F.); MS Center at Swedish Neuroscience Inst, Seattle, Wash (P.Q., C.T.); Dept of Neurology and Neuroimmunology Clinic, Rabin Medical Center, Petach Tikva, Israel (I.L.); Sackler Faculty of Medicine & Felsenstein Medical Research Center, Tel Aviv Univ, Tel Aviv, Israel (I.L., H.S.K.); Dept of Radiology, Rabin Medical Center, Beilinson Hosp, Israel, and Sackler Faculty of Medicine, Tel-Aviv Univ, Tel Aviv, Israel (V.K.); Dept of Neurology and Neuroimmunology, Rabin Medical Center, Beilinson Hosp, Israel, and Sackler Faculty of Medicine, Tel-Aviv Univ, Tel Aviv, Israel (M.A.H.); Neuro-Ophthalmology Div, Dept of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel (H.S.K.); Div of Neurology, Univ of Toronto, St Michael's Hosp, Toronto, Canada (D.L.R., L.W.); Mellen Center, Cleveland Clinic, Cleveland, Ohio (D.O.), Dept of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio (K.N.); Multiple Sclerosis and Neuroimmunology Program, Univ Hosps of Cleveland, Case Western Reserve Univ School of Medicine, Cleveland, Ohio (H.A., M.O.S.); Michigan Inst for Neurologic Disorders, Farmington Hills, Mich (Y.M.D.); Inst of Clinical Neuroimmunology, LMU Hosp, Ludwig-Maximillians Universität München, Munich, Germany (J.H.); Dept of Neurology, Slagelse Hosps, Odense, Denmark (N.A.); Insts of Regional Health Research & Molecular Medicine, Univ of Southern Denmark, Odense, Denmark (N.A.); Dept of Radiology, Aleris Hosp, Copenhagen, Denmark (P.B.S.); NYU Multiple Sclerosis Comprehensive Care Center, Dept of Neurology, NYU School of Medicine, New York, NY (I.K.); Dept of Neurology, Center for Neurology and Neuropsychiatry, LVR-Klinikum, Heinrich Heine Univ Düsseldorf, Düsseldorf, Germany (M.R.); School of Medicine and Dentistry, Gold Coast Campus, Griffith Univ, Queensland, Australia (S.B., S.A.); Dept of Neurology, Gold Coast Univ Hosp, Queensland, Australia (S.A.); Dept of Pediatrics, Univ of Utah, Salt Lake City, Utah (B.M., A.M.J., M.W., S.G., L.J.C.); Dept of Medicine, Divs of Molecular Medicine & Infectious Diseases, and Ludquist Inst for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, Calif (M.R.Y.); Dept of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, Calif (M.R.Y.); Depts of Ophthalmology and Visual Sciences, Kellogg Eye Center, Univ of Michigan, Ann Arbor, Mich (T.J.S.); Div of Metabolism, Endocrine and Diabetes, Dept of Internal Medicine, Univ of Michigan Medical School, Ann Arbor, Mich (T.J.S.); Hoffmann-LaRoche, Basel, Switzerland (J.W.); Dept of Neurology, Charité-Universitätsmedizin Berlin, Germany (F.P.); Affiliated author members of the Guthy-Jackson Charitable Foundation (GJCF) International Clinical Consortium (ICC) for NMOSD are listed in Appendix S1.

Article Synopsis
  • Patients with neuromyelitis optica spectrum disorder (NMOSD) often have antibodies against aquaporin-4 (AQP4), making MRI monitoring critical for understanding the disease's progression.
  • A retrospective study involved MRI data from 525 AQP4-IgG-seropositive NMOSD patients across 11 countries, focusing on the types and locations of lesions in the central nervous system.
  • Results showed a high prevalence of hyperintense lesions in the brain and significant patterns of myelitis in the spinal cord, emphasizing the importance of MRI in tracking this condition.
View Article and Find Full Text PDF

Surface-enhanced Raman spectroscopy (SERS) was utilized to measure low-level fentanyl concentrations mixed in common cutting agents, cocaine, 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine, and caffeine. Mixtures were prepared with a fentanyl concentration range of 0-339 μM. Data was initially analyzed by plotting the area of a diagnostic peak (1026 cm) against concentration to generate a calibration model.

View Article and Find Full Text PDF

Development of Functional Biointerface Using Mixed Zwitterionic Silatranes.

Langmuir

November 2024

Department of Chemical & Materials Engineering, National Central University, Jhong-Li, Taoyuan 320, Taiwan.

Strategies to design multifunctional interfaces for biosensors have been extensively investigated to acquire optimal sensitivity, specificity, and accuracy. However, heterogeneous ingredients in clinical samples inevitably generate background signals, exposing challenges in biosensor performance. Polymer coating has been recognized as a crucial method to functionalize biointerfaces by providing tailored properties that are essential for interacting with biological systems.

View Article and Find Full Text PDF

Vitamin D and cardiovascular outcomes in multiple sclerosis.

Mult Scler Relat Disord

December 2024

Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Cardiovascular Health Sciences, Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool L3 5UX, United Kingdom.

Article Synopsis
  • * An observational study of 74,372 pwMS over 5 years found that 9% had deficient and 18% had inadequate vitamin D levels, both associated with a higher incidence of major adverse cardiovascular events (MACE).
  • * Vitamin D supplementation (cholecalciferol) did not reduce the elevated CVD risk in pwMS with deficient or inadequate vitamin D levels compared to those with adequate levels.
View Article and Find Full Text PDF

Multifunctional effects of nitrification and urease inhibitors: Decreasing soil herbicide residues and reducing nitrous oxide emissions simultaneously.

Ecotoxicol Environ Saf

November 2024

Jiangxi Key Laboratory of Subtropical Forest Resources Cultivation, College of Forestry, Jiangxi Agricultural University, Nanchang 330045,  China; Research Institute of Tropical Forestry, Chinese Academy of Forestry, Guangzhou 510520, China. Electronic address:

Glyphosate pollution and greenhouse gas emissions are major problem in achieving sustainable soil management. It is necessary to develop effective strategies to simultaneously reduce herbicide residues and nitrous oxide (NO) emissions in soil. This study aimed to: (1) quantitative analyze the effects of nitrogen (N) cycle inhibitors (nitrification inhibitors 3,4 dimethylpyrazole phosphate (DMPP) and dicyandiamide (DCD) and urease inhibitor N-(n-butyl) thiophosphoric triamide (NBPT)) on glyphosate degradation and reduction of NO under different soil moistures; (2) identify the functional microbes and genes associated with glyphosate degradation and NO emissions; and (3) decipher the main mechanisms of N cycle inhibitors affecting glyphosate degradation at different soil water contents.

View Article and Find Full Text PDF

The role of amino acid PET in radiotherapy target volume delineation for adult-type diffuse gliomas: A review of the literature.

Crit Rev Oncol Hematol

January 2025

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales, Australia; The Brain Cancer Group, Sydney, New South Wales, Australia; Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia.

Purpose: To summarise existing literature examining amino acid positron emission tomography (AA-PET) for radiotherapy target volume delineation in patients with gliomas.

Methods: Systematic search of MEDLINE and EMBASE databases.

Results: Twenty studies met inclusion criteria.

View Article and Find Full Text PDF

Altrenogest, also known as allyltrenbolone, is a synthetic form of progesterone used therapeutically to suppress unwanted symptoms of estrus in female horses. Altrenogest affects the system by decreasing levels of endogenous gonadotrophin and luteinizing and follicle-stimulating hormones, which in turn decreases estrogen and mimics the increase of progesterone production. This results in more manageable mares for training and competition alongside male horses while improving the workplace safety of riders and handlers.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the effects of non-nutritive sweeteners (NNS) on glucose absorption and gut microbiota in mice, revealing that NNS increases glucose absorption without relying on gut microbiota.
  • - Mice given antibiotics to reduce gut microbiota showed improved glucose tolerance, suggesting that gut bacteria play an important role in glycemic responses.
  • - Results indicate that while NNS enhances glucose absorption, it does not negatively affect glycemic responses, and gut microbiota depletion positively impacts glucose tolerance through the activity of GLP-1.
View Article and Find Full Text PDF

Arsenic trioxide (ATO) has been shown to inhibit pancreatic cancer (PC) cell growth and to promote the inhibitory effects of gemcitabine (Gem) on PC . However, the high toxicity of ATO associated with the required high doses and indiscriminate targeting has limited its clinical application. This study aimed to determine whether coupling arsenic to a tumor homing peptide would increase the inhibitory potency against PC cells.

View Article and Find Full Text PDF

A Unique Case of Adoption in Golden Snub-Nosed Monkeys.

Animals (Basel)

October 2024

Shaanxi Key Laboratory for Animal Conservation, Northwest University, Xi'an 710069, China.

Adoption among nonhuman primates (hereafter primates) has been widely reported, particularly in chimpanzees, renowned for their higher intelligence and well-developed cognition. In contrast to adoption in other Old World monkeys, this case of adoption in golden snub-nosed monkeys () involves two infants associated with three units characterized by distinct social structures and reproductive functions. Consequently, this case extends beyond traditional hypotheses on allomaternal care and adoption-such as enhancing the fitness of adoptive mothers, fostering maternal behaviors, and improving fitness through social and individual interactions-to necessitate an association with the complex social structure characterized by hierarchical, multilevel composition, akin to human society, and intense sexual selection that frequently results in infanticide.

View Article and Find Full Text PDF

Molecular signatures of cortical expansion in the human foetal brain.

Nat Commun

November 2024

Department of Child and Adolescent Psychiatry and Behavioral Sciences, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

The third trimester of human gestation is characterised by rapid increases in brain volume and cortical surface area. Recent studies have revealed a remarkable molecular diversity across the prenatal cortex but little is known about how this diversity translates into the differential rates of cortical expansion observed during gestation. We present a digital resource, μBrain, to facilitate knowledge translation between molecular and anatomical descriptions of the prenatal brain.

View Article and Find Full Text PDF

Introduction: Improving support options for people who use methamphetamine is of critical national and global importance. The role of mutual-help groups within the treatment-seeking journey of people who use methamphetamine is unclear. Self-Management and Recovery Training ('SMART Recovery') mutual-help groups are led by a trained facilitator and support participants to work on individual goals, including, but not limited to abstinence.

View Article and Find Full Text PDF

Ibrutinib and venetoclax combination therapy for mantle cell lymphoma: are two better than one?

Expert Rev Hematol

December 2024

Clinical Haematology, Alfred Hospital, Melbourne, Victoria, Australia.

Article Synopsis
  • * The article examines the effectiveness of combining ibrutinib and venetoclax in treating relapsed or refractory MCL based on findings from two clinical studies: the AIM study, which involves a run-in period with ibrutinib, and the SYMPATICO study, which administers both drugs simultaneously.
  • * It suggests that this combination therapy may be effective and could eventually allow for fixed-duration treatment; ongoing research into measurable residual disease may help determine which patients can safely stop treatment after
View Article and Find Full Text PDF
Article Synopsis
  • * The study analyzed over 11,000 sources to assess stillbirth rates across 204 countries from 1990 to 2021, using varied definitions and gestational age benchmarks for clarity.
  • * In 2021, the global stillbirth rate was 23.0 per 1,000 births at 20 weeks or longer, with a neonatal mortality rate of 17.1 per 1,000 live births, indicating a concerning level of both stillbirths and neonatal deaths worldwide.
View Article and Find Full Text PDF

Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studies.

EBioMedicine

December 2024

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA; Harvard Medical School, Boston, MA, 02115, USA. Electronic address:

Background: Genetic variants and gene expression predict risk of chronic obstructive pulmonary disease (COPD), but their effect on COPD heterogeneity is unclear. We aimed to define high-risk COPD subtypes using genetics (polygenic risk score, PRS) and blood gene expression (transcriptional risk score, TRS) and assess differences in clinical and molecular characteristics.

Methods: We defined high-risk groups based on PRS and TRS quantiles by maximising differences in protein biomarkers in a COPDGene training set and identified these groups in COPDGene and ECLIPSE test sets.

View Article and Find Full Text PDF

Ankle and Foot Injuries in the Emergency Department: Checklist-based Approach to Radiographs.

Radiographics

December 2024

From the North Bengal Medical College, Bengal, India (D.P.); Department of Radiology and Molecular Imaging, Sultan Qaboos University Hospital, PO Box 38, PC 123, Al Khoud, Muscat, Oman (S.B.R., A.K.M.); Innovision Imaging, Mumbai, India (A.A.); Lumus Imaging, Brisbane, Australia (J.P.); and University of Texas Health Science Center at Houston, Houston, Tex (M.K.).

View Article and Find Full Text PDF